Publication | Closed Access
A phase-III trial of doxorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breast cancer: results of the ERASME 3 study
46
Citations
18
References
2007
Year
Metastatic Breast CancerOncologyBreast OncologyPharmacologyPhase-iii TrialErasme 3Breast CancerPharmacotherapyCancer TreatmentMedicine
| Year | Citations | |
|---|---|---|
Page 1
Page 1